These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 29920062

  • 1. Generation of Potent Anti-HER1/2 Immunotoxins by Protein Ligation Using Split Inteins.
    Pirzer T, Becher KS, Rieker M, Meckel T, Mootz HD, Kolmar H.
    ACS Chem Biol; 2018 Aug 17; 13(8):2058-2066. PubMed ID: 29920062
    [Abstract] [Full Text] [Related]

  • 2. Modular Conjugation of a Potent Anti-HER2 Immunotoxin Using Coassociating Peptides.
    Stoessel A, Groysbeck N, Guyot L, Barret L, Nominé Y, Nguekeu-Zebaze L, Bender A, Voilquin L, Lutz T, Pallaoro N, Blocat M, Deville C, Masson M, Zuber G, Chatton B, Donzeau M.
    Bioconjug Chem; 2020 Oct 21; 31(10):2421-2430. PubMed ID: 32996763
    [Abstract] [Full Text] [Related]

  • 3. Soluble Cytoplasmic Expression and Purification of Immunotoxin HER2(scFv)-PE24B as a Maltose Binding Protein Fusion.
    Park S, Nguyen MQ, Ta HKK, Nguyen MT, Lee G, Kim CJ, Jang YJ, Choe H.
    Int J Mol Sci; 2021 Jun 17; 22(12):. PubMed ID: 34204265
    [Abstract] [Full Text] [Related]

  • 4. Target-specific cytotoxic effects on HER2-expressing cells by the tripartite fusion toxin ZHER2:2891-ABD-PE38X8, including a targeting affibody molecule and a half-life extension domain.
    Liu H, Seijsing J, Frejd FY, Tolmachev V, Gräslund T.
    Int J Oncol; 2015 Aug 17; 47(2):601-9. PubMed ID: 26046132
    [Abstract] [Full Text] [Related]

  • 5. Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors.
    Zielinski R, Lyakhov I, Jacobs A, Chertov O, Kramer-Marek G, Francella N, Stephen A, Fisher R, Blumenthal R, Capala J.
    J Immunother; 2009 Oct 17; 32(8):817-25. PubMed ID: 19752752
    [Abstract] [Full Text] [Related]

  • 6. Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems.
    Della Cristina P, Castagna M, Lombardi A, Barison E, Tagliabue G, Ceriotti A, Koutris I, Di Leandro L, Giansanti F, Vago R, Ippoliti R, Flavell SU, Flavell DJ, Colombatti M, Fabbrini MS.
    Microb Cell Fact; 2015 Feb 13; 14():19. PubMed ID: 25889802
    [Abstract] [Full Text] [Related]

  • 7. Preparation of Diphtheria and Pseudomonas Exotoxin A Immunotoxins and Evaluation of Their Cytotoxicity Effect on SK-BR-3, BT-474, and MDA-MB-231 Breast Cancer Cell Lines.
    Amoozadeh S, Hemmati M, Farajollahi MM, Akbari N, Tarighi P.
    Cancer Invest; 2019 Feb 13; 37(10):546-557. PubMed ID: 31597492
    [Abstract] [Full Text] [Related]

  • 8. Expression of VGRNb-PE immunotoxin in transplastomic lettuce (Lactuca sativa L.).
    Mirzaee M, Jalali-Javaran M, Moieni A, Zeinali S, Behdani M.
    Plant Mol Biol; 2018 May 13; 97(1-2):103-112. PubMed ID: 29633168
    [Abstract] [Full Text] [Related]

  • 9. A chemical conjugate between HER2-targeting antibody fragment and Pseudomonas exotoxin A fragment demonstrates cytotoxic effects on HER2-expressing breast cancer cells.
    Lee S, Park S, Nguyen MT, Lee E, Kim J, Baek S, Kim CJ, Jang YJ, Choe H.
    BMB Rep; 2019 Aug 13; 52(8):496-501. PubMed ID: 30670149
    [Abstract] [Full Text] [Related]

  • 10. [Studies of the expression, purification, renaturation and biologic activity of an anti-CEA immunotoxin].
    Yang H, He D, Chao K, Lin Q, You S, Huang HL.
    Sheng Wu Gong Cheng Xue Bao; 2004 May 13; 20(3):348-51. PubMed ID: 15971603
    [Abstract] [Full Text] [Related]

  • 11. Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells.
    Tur MK, Huhn M, Thepen T, Stöcker M, Krohn R, Vogel S, Jost E, Osieka R, van de Winkel JG, Fischer R, Finnern R, Barth S.
    Cancer Res; 2003 Dec 01; 63(23):8414-9. PubMed ID: 14679004
    [Abstract] [Full Text] [Related]

  • 12. EGF ligand fused to truncated Pseudomonas aeruginosa exotoxin A specifically targets and inhibits EGFR‑positive cancer cells.
    Hashimi SM, Grant B, Alqurashi N, Alowaidi F, Wei MQ.
    Oncol Rep; 2018 Nov 01; 40(5):2690-2697. PubMed ID: 30226622
    [Abstract] [Full Text] [Related]

  • 13. Breast cancer targeted/ therapeutic with double and triple fusion Immunotoxins.
    Goleij Z, Mahmoodzadeh Hosseini H, Sedighian H, Behzadi E, Halabian R, Sorouri R, Imani Fooladi AA.
    J Steroid Biochem Mol Biol; 2020 Jun 01; 200():105651. PubMed ID: 32147458
    [Abstract] [Full Text] [Related]

  • 14. Construction, expression, and characterization of an anti-tumor immunotoxin containing the human anti-c-Met single-chain antibody and PE38KDEL.
    Liu Z, Feng Z, Zhu X, Xu W, Zhu J, Zhang X, Fan Z, Ji G.
    Immunol Lett; 2013 Jan 01; 149(1-2):30-40. PubMed ID: 23026237
    [Abstract] [Full Text] [Related]

  • 15. Novel recombinant anti-HER2/neu immunotoxin: design and antitumor efficiency.
    Sokolova EA, Zdobnova TA, Stremovskiy OA, Balalaeva IV, Deyev SM.
    Biochemistry (Mosc); 2014 Dec 01; 79(12):1376-81. PubMed ID: 25716732
    [Abstract] [Full Text] [Related]

  • 16. [Construction, expression and functional characterization of disulfide-stabilized anti-hepatocarcinoma single chain Fv fused with truncated Pseudomonas exotoxin].
    Zhao J, Sun ZW, Liu YF, Yu WY.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov 01; 19(6):585-7. PubMed ID: 15182657
    [Abstract] [Full Text] [Related]

  • 17. Cloning, expression and characterization of a HER2-alpha luffin fusion protein in Escherichia coli.
    Barkhordari F, Sohrabi N, Davami F, Mahboudi F, Garoosi YT.
    Prep Biochem Biotechnol; 2019 Nov 01; 49(8):759-766. PubMed ID: 31032734
    [Abstract] [Full Text] [Related]

  • 18. Novel Anti-Mesothelin Nanobodies and Recombinant Immunotoxins with Pseudomonas Exotoxin Catalytic Domain for Cancer Therapeutics.
    Nguyen MQ, Kim DH, Shim HJ, Ta HKK, Vu TL, Nguyen TKO, Lim JC, Choe H.
    Mol Cells; 2023 Dec 31; 46(12):764-777. PubMed ID: 38052492
    [Abstract] [Full Text] [Related]

  • 19. Pseudomonas exotoxin and recombinant immunotoxins derived from it.
    Fitzgerald D, Pastan I.
    Ann N Y Acad Sci; 1993 Jun 23; 685():740-5. PubMed ID: 8363279
    [Abstract] [Full Text] [Related]

  • 20. Bivalent disulfide-stabilized fragment variable immunotoxin directed against mesotheliomas and ovarian cancer.
    Bera TK, Williams-Gould J, Beers R, Chowdhury P, Pastan I.
    Mol Cancer Ther; 2001 Dec 23; 1(2):79-84. PubMed ID: 12467225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.